Analyze Diet

Topic:Hormones

Hormones in horses are chemical messengers produced by various glands and tissues, regulating numerous physiological processes essential for maintaining homeostasis. These hormones influence a wide range of functions, including growth, metabolism, reproduction, and stress responses. Key hormones in equine physiology include cortisol, estrogen, testosterone, and insulin, among others. The levels and effects of these hormones can vary based on factors such as age, sex, and environmental conditions, impacting overall health and performance. This page compiles peer-reviewed research studies and scholarly articles that explore the production, regulation, and physiological roles of hormones in equine biology.
Effect of 2-deoxy-D-glucose on gonadotropins, prolactin and serum glucose concentrations in the mare.
Animal reproduction science    June 6, 2002   Volume 71, Issue 3-4 217-228 doi: 10.1016/s0378-4320(02)00030-1
McManus CJ, Davison LA, Fitzgerald BP.In a variety of species, glucoprivation results in the suppression of the reproductive axis. Two experiments were performed to test the hypothesis that blockade of glucose metabolism via administration of the glucose inhibitor 2-deoxy-D-glucose (2DG) to mares would cause a modification in gonadotropin and prolactin secretion. Long-term ovariectomized mares (Experiment 1, n=4) or ovary-intact mares during the follicular phase of a synchronized estrous cycle (Experiment 2, n=4 per dose) were treated with 2DG. The dose of 2DG used in Experiment 1 was 100mg 2DG/kg BW, but because severe behavioral...
Growth hormone or insulin-like growth factor-I extends longevity of equine spermatozoa in vitro.
Theriogenology    June 4, 2002   Volume 57, Issue 7 1793-1800 doi: 10.1016/s0093-691x(02)00640-4
Champion ZJ, Vickers MH, Gravance CG, Breier BH, Casey PJ.Growth hormone (GH) and insulin-like growth factor-I (IGF-I) are both present in blood plasma and IGF-I has been measured in epididymal fluid and seminal plasma. This study was designed to investigate the direct effects of GH or IGF-I on the motility of mature equine spermatozoa in vitro. We compared the effects of one concentration (100 ng/ml) of recombinant bovine GH (rbGH) and recombinant human IGF-I (rhIGF-I) on motility and motion characteristics of equine spermatozoa over a 24 h period. Motility was maintained longer in spermatozoa treated with either rbGH or rhIGF-I during a 24 h period...
Inhibin concentrations in mares with granulosa cell tumors.
Theriogenology    June 4, 2002   Volume 57, Issue 7 1885-1895 doi: 10.1016/s0093-691x(02)00658-1
Bailey MT, Troedsson MH, Wheato JE.The hormone-producing equine granulosa cell tumor (GCT) may secrete high levels of inhibin. Measurement of inhibin concentrations may be useful in the diagnosis and conformation of mares with GCT. Inhibin may be measured using RIA, which recognizes dimeric alphabetaA-inhibin as well as the monomeric (free) inhibin alpha-subunit, or using a two-site immunoradiometric assay (IRMA) specific for alphabetaA-inhibin. The objective of this study was to examine concurrent relationships among alpha-inhibin (as measured using RIA), alphabetaA-inhibin (as measured using IRMA), and other hormones (testost...
Species differences in GnRH activation of the LHbeta promoter: role of Egr1 and Sp1.
Molecular and cellular endocrinology    June 1, 2002   Volume 189, Issue 1-2 85-96 doi: 10.1016/s0303-7207(01)00744-4
Call GB, Wolfe MW.Activation of the luteinizing hormone beta (LHbeta) promoter by gonadotropin-releasing hormone (GnRH) via the transcription factor early growth response protein-1 (Egr1) has been well characterized. To determine the mechanisms affecting Egr1 regulation of LHbeta, we analyzed five different species of LHbeta promoters (equine, mouse, rat, bovine and human). Electrophoretic mobility shift assays (EMSAs) identified multiple transcription factors binding to the Egr regions on the LHbeta promoter. Species-specific differences existed in the binding affinity for Sp1, Sp3, steroidogenic factor-1 (SF-...
Mechanisms responsible for increase in circulating inhibin levels at the time of ovulation in mares.
Theriogenology    May 31, 2002   Volume 57, Issue 6 1707-1717 doi: 10.1016/s0093-691x(02)00683-0
Nambo Y, Nagaoka K, Tanaka Y, Nagamine N, Shinbo H, Nagata S, Yoshihara T, Watanabe G, Groome NP, Taya K.In female mammals, inhibin is secreted by the granulosa cells and selectively inhibits secretion of FSH. Although circulating immunoreactive (ir)-inhibin levels decrease after ovulation as a result of the disappearance of its main source, they abruptly increase at the time of ovulation in mares. To investigate the mechanisms responsible for this increase, 50 ml of equine follicular fluid (eFF) was administered into the abdominal cavity of mares during the luteal phase (eFF, n = 4). One hour after treatment, plasma levels of ir-inhibin and inhibin pro-alphaC (but not estradiol-17beta) were sign...
Exercise-induced changes in atrial peptides in relation to neuroendocrine responses and fluid balance in the horse.
Journal of veterinary medicine. A, Physiology, pathology, clinical medicine    May 22, 2002   Volume 49, Issue 3 144-150 doi: 10.1046/j.1439-0442.2002.00428.x
Kokkonen UM, Pösö AR, Hyyppä S, Huttunen P, Leppäluoto J.Previous data show that, in horses, plasma atrial natriuretic peptides (ANP and NT-ANP) remain elevated for a long time after exercise. To study whether exercise-induced changes in hormonal and fluid balance explain this, we measured plasma concentrations of COOH- and NH2-terminal atrial natriuretic peptides (ANP(99-129) and NT-ANP(1-98) together with arginine vasopressin (AVP), adrenocorticotrophin (ACTH), beta-endorphin, cortisol, catecholamines, and indicators of fluid balance in six Finnhorses after a graded submaximal exercise test on a treadmill. After exercise, AVP and catecholamines di...
Immunization against gnRH in mature mares: antibody titres, ovarian function, hormonal levels and oestrous behaviour.
Journal of veterinary medicine. A, Physiology, pathology, clinical medicine    May 22, 2002   Volume 49, Issue 3 125-131 doi: 10.1046/j.1439-0442.2002.00427.x
Dalin AM, Andresen O, Malmgren L.The aim of the present study was to investigate the effect of active immunization against GnRH in mature Standardbred mares (three experimental and one control mare) on antibody titres, ovarian function, hormonal levels and oestrous behaviour. The mares were individually teased with a stallion once each day. During the first part of the experiment (period I: late April until November), blood was sampled every third day during the first 3 months, thereafter once per week. In the second part of the experiment (period II: December until August), sampling was carried out every second week. Progest...
Effect of follicle size on in vitro production of steroids and insulin-like growth factor (IGF)-I, IGF-II, and the IGF-binding proteins by equine ovarian granulosa cells.
Biology of reproduction    May 22, 2002   Volume 66, Issue 6 1640-1648 doi: 10.1095/biolreprod66.6.1640
Davidson TR, Chamberlain CS, Bridges TS, Spicer LJ.Little is known regarding the hormonal regulation of granulosa cell steroidogenesis and the ovarian insulin-like growth factor (IGF) system in the mare. The objectives of this study were to determine, first, if estradiol, insulin, and/or FSH affect steroid production by equine granulosa cells (experiment 1) and, second, if the components of the IGF system are produced by equine granulosa cells in culture as well as whether estradiol, insulin, and/or FSH affects IGF and/or IGF-binding protein (IGFBP) production by equine granulosa cells (experiment 2). Granulosa cells from small (6-15 mm), medi...
Equine placentation.
Reproduction, fertility, and development    May 10, 2002   Volume 13, Issue 7-8 623-634 doi: 10.1071/rd01063
Allen WR, Stewart F.A tough, elastic glycoprotein capsule envelops the equine blastocyst between Days 6 and 23 after ovulation. It maintains the spherical configuration of, and provides physical support for, the embryo as it traverses the entire uterine lumen during Days 6-17, propelled by myometrial contractions that are stimulated by pulsatile release of prostaglandin F2alpha and prostaglandin E2. The capsule also accumulates constituents of the exocrine secretions of the endometrial glands ('uterine milk') as nutrients for the mobile embryo as it releases its antiluteolytic maternal recognition-of-pregnancy si...
The equine hypophysis: a gland for all seasons.
Reproduction, fertility, and development    May 10, 2002   Volume 13, Issue 7-8 591-597 doi: 10.1071/rd01066
Tortonese DJ, Gregory SJ, Eagle RC, Sneddon CL, Young CL, Townsend J.The intrahypophysial mechanisms involved in the control of gonadotrophin secretion remain unclear. In the horse, a divergent pattern of gonadotrophins is observed at different stages of the reproductive cycle in response to a single secretagogue (gonadotrophin-releasing hormone), and dramatic changes in fertility take place throughout the year in response to photoperiod. This species thus provides a useful model to investigate the regulation of fertility directly at the level of the hypophysis. A series of studies were undertaken to examine the cytological arrangements and heterogeneity of gon...
Uterine involution, day and variance of first postpartum ovulation in mares treated with progesterone and estradiol-17beta for 1 or 2 days postpartum.
Theriogenology    May 7, 2002   Volume 57, Issue 2 989-995 doi: 10.1016/s0093-691x(01)00703-8
Bruemmer JE, Brady HA, Blanchard TL.The effects of a single or double regimen of exogenous progesterone and estradiol-17beta (P/E, total dose 300 mg P/20 mg E) were investigated in 50 postparturient Quarter Horse mares. In Trial 1, at 1 and 24 h after foaling, mares were injected with progesterone (150 mg) and estradiol-17beta (10 mg) (n = 7) or 0.9% NaCl (control, n = 13). In Trial 2, within 12 h after foaling, mares were injected with progesterone (300 mg) and estradiol-17beta (20 mg) (n = 13) or 0.9% NaCl (control, n = 17). Mares were examined daily by palpation per rectum and transrectal ultrasonography to determine the day ...
The new conundrum: do estrogens have any cardiovascular benefits?
International journal of fertility and women's medicine    May 7, 2002   Volume 47, Issue 2 61-68 
Clarkson TB.Clearly, a new era has begun, with increasing numbers of the scientific/medical community asking whether estrogens have any cardiovascular benefits. Doubts have arisen from two randomized prospective trials. The Heart and Estrogen/progestin Replacement Study (women who were generally beyond 65 years of age with preexisting coronary heart disease) found no benefit in reducing coronary events by a combination of estrogens and a progestin. Later, the Estrogen Replacement Atherosclerosis Trial reported that no benefit could be shown for either conjugated equine estrogens only or the combined thera...
Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha.
Chemical research in toxicology    April 16, 2002   Volume 15, Issue 4 512-519 doi: 10.1021/tx0101649
Liu X, Yao J, Pisha E, Yang Y, Hua Y, van Breemen RB, Bolton JL.Excessive exposure to synthetic and endogenous estrogens has been associated with the development of cancer in several tissues. 4-Hydroxyequilenin (4-OHEN), a major metabolite of equine estrogens present in estrogen replacement formulations, has been shown to induce cytotoxic/carcinogenic effects. In the present study, we have found that 4-OHEN caused DNA damage in breast cancer cells, and cells that contain estrogen receptor alpha (S30) are more sensitive to 4-OHEN-mediated DNA damage as compared to estrogen receptor negative cells (MDA-MB-231). For example, concentration-dependent increases ...
Effects of frequency of treatment with recombinant equine somatotropin on selected biological responses in geldings.
Domestic animal endocrinology    April 6, 2002   Volume 22, Issue 3 127-143 doi: 10.1016/s0739-7240(02)00120-0
Thatcher CE, Thompson DL.Two experiments compared the efficacies of different treatment frequencies for recombinant equine somatotropin (eST). In Experiment 1, five geldings received daily injections of eST at 20 microg/kg of body weight, and five received every-other-day injections at 40 microg/kg of body weight, for a total of 30 days. Plasma glucose (P=0.0001), insulin (P=0.0135), and non-esterified fatty acid (NEFA, P=0.0001) concentrations increased, and plasma urea nitrogen (PUN) concentrations decreased (P=0.0001), in both groups, and only minor differences (P<0.05) occurred between the two groups. Insulin-like...
Plasma FSH, inhibin A and inhibin isoforms containing pro- and -alphaC during winter anoestrus, spring transition and the breeding season in mares.
Reproduction (Cambridge, England)    March 27, 2002   Volume 123, Issue 4 535-542 
Watson ED, Heald M, Tsigos A, Leask R, Steele M, Groome NP, Riley SC.Ten mares were studied from February (winter anoestrus) to their second ovulation in the breeding season to investigate the relationship between resumption of ovarian cyclicity in the spring and circulating concentrations of FSH, inhibin A and inhibin isoforms containing pro- and -alphaC immunoreactivity. An additional four mares were studied during one oestrous cycle. Growth and regression of ovarian follicles were monitored by transrectal ultrasonography. The frequency of blood sampling varied from three times a week to once a day, depending on the follicular activity present. Concentrations...
Effects of LH and PGF2alpha in equine dominant follicles observed by MDS.
The Journal of veterinary medical science    March 27, 2002   Volume 64, Issue 2 119-122 doi: 10.1292/jvms.64.119
Kojima AY, Kobayashi S, Acosta TJ, Kudo M, Miyamoto A, Takagi M, Miyazawa K, Sato K.Microdialysis System (MDS) is a novel technique used for investigation of molecule secretion between different cell populations. Local hormonal secretion at follicular wall has been still unclear. This MDS study was used to determine progesterone (P4), androstenedione (A4), estradiol-17beta (E2) and Prostaglandin F2alpha (PGF2alpha) release in mare pre-ovulatory follicles. Follicles larger than 30 mm were isolated from the ovary and follicular fluid aspirated for hormone assay. Follicular fluid collected from small, middle and large follicles were analyzed by EIA. The concentrations of P4 and ...
Changes in concentrations of follicular fluid factors during follicle selection in mares.
Biology of reproduction    March 22, 2002   Volume 66, Issue 4 1111-1118 doi: 10.1095/biolreprod66.4.1111
Donadeu FX, Ginther OJ.The temporal relationships in the changes in concentrations of follicular fluid factors during follicle selection were characterized in mares. All follicles > or =5 mm were ablated 10 days after ovulation, followed by follicular fluid collection from the three largest follicles (F1, F2, and F3) when F1 of the new wave reached a diameter of 8.0-11.9, 12.0-15.9, 16.0-19.9, 20.0-23.9, 24.0-27.9, or 28.0-31.9 mm (n = 4-8 mares/range). Diameter deviation between F1 and F2 began during the 20.0- to 23.9-mm range, as indicated by a greater difference in diameter between the two follicles at the 24...
Effectiveness of a two-dose regimen of prostaglandin administration in inducing luteolysis without adverse side effects in mares.
Equine veterinary journal    March 22, 2002   Volume 34, Issue 2 191-194 doi: 10.2746/042516402776767240
Irvine CH, McKeough VL, Turner JE, Alexander SL, Taylor TB.Our objectives were to determine whether repeated administration of prostaglandin F2alpha (PGF2alpha) to simulate the endogenous mode of secretion would be more effective than a single injection in inducing luteolysis and enable use of smaller doses less likely to cause adverse side effects. The main study comprised 43 dioestrous mares, who were given im. either a single 10 mg dose of natural PGF2alpha (n = 22) or 2 doses of 0.5 mg PGF2, 24 h apart (n = 21). The intensity of side effects was assessed in 8 dioestrous mares given 5, 1.5, 0.5 or 0 mg PGF2alpha in consecutive cycles. Two doses of ...
Detection of high circulating concentrations of inhibin pro- and -alphaC immunoreactivity in mares with granulosa-theca cell tumours.
Equine veterinary journal    March 21, 2002   Volume 34, Issue 2 203-206 doi: 10.2746/042516402776767196
Watson ED, Heald M, Leask R, Groome NP, Riley SC.No abstract available
Growth hormone response to a novel growth hormone-releasing tripeptide in horses: interaction with gonadotropin-releasing hormone, thyrotropin-releasing hormone, and sulpiride.
Journal of animal science    March 14, 2002   Volume 80, Issue 3 744-750 doi: 10.2527/2002.803744x
Kennedy SR, Thompson DL, Pruett HE, Burns PJ, Deghenghi R.A series of experiments was performed to determine the factor(s) responsible for an apparent inhibition of GH secretion in mares administered the GH secretagogue EP51389 in combination with GnRH, thyrotropin-releasing hormone (TRH), and sulpiride. Experiment 1 tested the repeatability of the original observation: 10 mares received EP51389 at 10 microg/kg BW; five received TRH (10 microg/kg BW), GnRH (1 microg/kg BW), and sulpiride (100 microg/kg BW) immediately before EP51389, and five received saline. The mixture of TRH, GnRH, and sulpiride reduced (P = 0.0034) the GH response to EP51389, con...
Free and conjugated estrogens and androgens in stallion semen.
General and comparative endocrinology    March 9, 2002   Volume 125, Issue 2 272-282 doi: 10.1006/gcen.2001.7747
Lemazurier E, Moslemi S, Sourdaine P, Desjardins I, Plainfosse B, Seralini GE.The steroid content of semen from a total of 11 mature fertile stallions was studied during two breeding seasons and one winter. The levels of free and conjugated substrates (testosterone and androstenedione), and products (estradiol and estrone), of aromatase were measured by radioimmunoassay with a validated method. The results were seasonally and monthly highly variable with characteristic peaks. The concentrations of free and conjugated estrogens were always higher in the gel-free ejaculate than in the gel except in one subfertile stallion used as comparison. Furthermore, the steroid produ...
Daily treatment of growing foals with equine somatotropin: pathologic and endocrinologic assessments at necropsy and residual effects in live animals.
Journal of animal science    March 8, 2002   Volume 80, Issue 2 392-400 doi: 10.2527/2002.802392x
Kulinski KM, Thompson DL, Capshaw EL, French DD, Oliver JL.This experiment assessed the effects of 12 mo of daily treatment of young horses with recombinant equine somatotropin (eST) on 1) carcass and internal organ traits at necropsy and 2) residual effects in live horses for 60 d after cessation of treatment. Seven horses received eST daily at 20 microg/kg BW; seven others received vehicle (controls). Four horses from each group were killed at the end of treatment. There were few effects of eST treatment on hematologic assessments or histopathologic evaluations of internal organs. Treatment with eST increased the weights of the right adrenal gland (...
The testis as a major source of circulating inhibins in the male equine fetus during the second half of gestation.
Journal of andrology    March 1, 2002   Volume 23, Issue 2 229-236 
Tanaka Y, Taniyama H, Tsunoda N, Shinbo H, Nagamine N, Nambo Y, Nagata S, Watanabe G, Herath CB, Groome NP, Taya K.Immunolocalization of the inhibin (a) and inhibin/activin (beta3A and betaB) subunit proteins in equine fetal testes was investigated to determine the ability of the fetal testis to produce inhibins at 120, 150, 200, and 250 days of gestation. In addition, concentrations of immunoreactive (ir)-inhibin, inhibin pro-aC, and inhibin A in both the maternal and fetal circulation were measured. It was found that plasma concentrations of ir-inhibin, inhibin pro-alphaC, and inhibin A were much higher (P < .05) in the fetal than in the maternal circulation at any stage of gestation examined. Similar...
Looking for the pony in the HERS data. Heart and Estrogen/progestin Replacement Study.
Circulation    February 28, 2002   Volume 105, Issue 8 902-903 
Barrett-Connor E.No abstract available
Prostaglandin E(2) and F(2 alpha) production by equine conceptuses and concentrations in conceptus fluids and uterine flushings recovered from early pregnant and dioestrous mares.
Reproduction (Cambridge, England)    February 28, 2002   Volume 123, Issue 2 261-268 
Stout TA, Allen WR.A growing equine conceptus must suppress the cyclical release of PGF(2 alpha) from the endometrium to effect maternal recognition of its presence in the uterus. Paradoxically, the conceptus itself secretes PGF(2 alpha), together with other prostaglandins. In this study, the PGF(2 alpha) and PGE(2) content of, and production in vitro by, day 10-32 equine conceptuses were measured and the influence of pregnancy on the concentrations of these prostaglandins in the uterine lumen was examined. In vitro, the release of both prostaglandins per mg conceptus tissue was very high on day 10 after ovulati...
The influence of maternal size on placental, fetal and postnatal growth in the horse. II. Endocrinology of pregnancy.
The Journal of endocrinology    February 9, 2002   Volume 172, Issue 2 237-246 doi: 10.1677/joe.0.1720237
Allen WR, Wilsher S, Stewart F, Stewart F, Ousey J, Ousey J, Fowden A.Within-breed artificial insemination and between-breed embryo transfer were carried out in small pony (P) and large Thoroughbred (Tb) mares to create 4 types of horse pregnancy in which the fetus experienced spatial and nutritional deprivation (Tb-in-P; n=8), luxury (P-in-Tb; n=7) or normality (Tb-in-Tb; n=7 and P-in-P; n=7) in utero. Measurement of equine chorionic gonadotrophin (eCG), total conjugated oestrogens and progestagen concentrations in serial peripheral serum samples recovered from all the mares throughout gestation showed that the amount of eCG produced during the first half of ge...
Changes in follicular fluid steroids, insulin-like growth factors (IGF) and IGF-binding protein concentration, and proteolytic activity during equine follicular development.
Journal of animal science    February 8, 2002   Volume 80, Issue 1 179-190 doi: 10.2527/2002.801179x
Bridges TS, Davidson TR, Chamberlain CS, Geisert RD, Spicer LJ.The objective of the present study was to evaluate changes in equine follicular fluid insulin-like growth factor binding protein (IGFBP) proteolytic activity as well as steroid, IGF, and IGFBP concentrations during follicular development in the mare. Mares (n = 14) were classified as either in the follicular phase (n = 8) or luteal phase (n = 6). Follicles (n = 92) were categorized as small (6 to 15 mm; n = 54), medium (16 to 25 mm; n = 23), or large (> 25 mm; n = 15), and follicular fluid was collected. Estradiol and androstenedione levels in follicular fluid were greater (P < 0.05), an...
Responses of seasonally anovulatory mares to daily administration of thyrotropin-releasing hormone and(or) gonadotropin-releasing hormone analog.
Journal of animal science    February 8, 2002   Volume 80, Issue 1 208-213 doi: 10.2527/2002.801208x
Gentry LR, Thompson DL, Stelzer AM.Seventeen seasonally anovulatory light horse mares were treated daily, starting January 5 (d 1), for 28 d with GnRH analog (GnRH-A; 50 ng/kg BW) and(or) thyrotropin-releasing hormone (TRH; 5 microg/kg BW) in a 2 x 2 factorial arrangement of treatments to test the hypothesis that combined treatment may stimulate follicular growth and development. Ovaries were examined via ultrasonography and jugular blood samples were collected every 3 d. Frequent blood samples were collected after treatment injections on d 1, 2, 4, 7, 11, 16, and 22; on d 29, all mares received an i.v. mixture of GnRH, TRH, su...
Thyroid-stimulating hormone in adult euthyroid and hypothyroid horses.
Journal of veterinary internal medicine    February 2, 2002   Volume 16, Issue 1 109-115 doi: 10.1892/0891-6640(2002)016<0109:tshiae>2.3.co;2
Breuhaus BA.The purpose of this study was to validate a thyroid-stimulating hormone (TSH) assay in a model of equine hypothyroidism. Thyrotropin-releasing hormone (TRH) stimulation tests were performed in 12 healthy adult mares and geldings, aged 4 to greater than 20 years. before and during administration of the antithyroid drug propylthiouracil (PTU) for 6 weeks. Serum concentrations of equine TSH, total and free thyroxine (T4), and total and free triiodothyronine (T3) were measured. Before PTU administration, mean +/- standard deviation baseline concentrations of TSH were 0.40 +/- 0.29 ng/mL. TSH incre...
Daily treatment of horses with equine somatotropin from 4 to 16 months of age.
Journal of animal science    January 29, 2002   Volume 79, Issue 12 3137-3147 doi: 10.2527/2001.79123137x
Capshaw EL, Thompson DL, Kulinski KM, Johnson CA, French DD.Fourteen foals between 4 and 4.5 mo of age were used to determine the effects of 12 mo of daily treatment with equine somatotropin (eST) on growth, metabolic, and hormonal characteristics. The foals were paired by sex, type, and lineage, and one of each pair was administered eST daily at 20 microg/kg of BW. Body weights, body measurements, and assessments of glucose tolerance and feedback effects on endogenous somatotropin (ST) secretion were made routinely. Treatment with eST did not alter (P > 0.10) BW, height at withers, length of body, widths of chest and rump, heart girth, length of he...
1 41 42 43 44 45 98